Patrick Wood
Stock Analyst at Morgan Stanley
(2.98)
# 1,533
Out of 4,996 analysts
105
Total ratings
46.15%
Success rate
1.39%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $84 → $76 | $67.55 | +12.51% | 6 | Aug 28, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $84 → $80 | $73.92 | +8.23% | 5 | Aug 21, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $184.60 | +6.72% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $249.08 | +18.44% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $113.87 | +8.02% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $14.50 | -10.34% | 8 | Aug 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $78 → $74 | $72.46 | +2.13% | 7 | Jul 31, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $36.66 | +85.49% | 3 | Jul 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Equal-Weight | $75 → $81 | $76.25 | +6.23% | 9 | Jul 15, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $82 → $89 | $67.10 | +32.64% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $27 | $21.98 | +22.84% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $9.03 | -0.33% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $71.37 | +44.32% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $125 | $98.18 | +27.32% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $79.92 | -9.91% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $119.99 | +44.18% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $22 | $12.00 | +83.33% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $318.00 | -0.31% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $5.46 | +83.15% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $26.80 | +38.06% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $130.80 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Aug 28, 2025
Maintains: Equal-Weight
Price Target: $84 → $76
Current: $67.55
Upside: +12.51%
Alcon
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $73.92
Upside: +8.23%
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $184.60
Upside: +6.72%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $249.08
Upside: +18.44%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $113.87
Upside: +8.02%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $14.50
Upside: -10.34%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $78 → $74
Current: $72.46
Upside: +2.13%
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $36.66
Upside: +85.49%
Edwards Lifesciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $76.25
Upside: +6.23%
DexCom
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $67.10
Upside: +32.64%
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $21.98
Upside: +22.84%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $9.03
Upside: -0.33%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $71.37
Upside: +44.32%
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $98.18
Upside: +27.32%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $79.92
Upside: -9.91%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $119.99
Upside: +44.18%
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $12.00
Upside: +83.33%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $318.00
Upside: -0.31%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $5.46
Upside: +83.15%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $26.80
Upside: +38.06%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $130.80
Upside: -